Vaccine T-cells may hold robust defensive line against Omicron variant: study

//Vaccine T-cells may hold robust defensive line against Omicron variant: study

Vaccine T-cells may hold robust defensive line against Omicron variant: study

The highly mutated coronavirus variant Omicron might be able to evade the body’s first line of immune defence but is unlikely to make it through the second – T-cells, according to the results of a computational study.In a peer-reviewed article published in the journal Viruses on Sunday, researchers in Hong Kong and Australia said T-cell responses induced by vaccines, boosters and previous infections could help protect against severe illness and hospitalisation from Omicron.But the number of…

Article by [author-name] (c) China - South China Morning Post - Read full story here.

By | 2022-01-03T10:35:43+00:00 January 3rd, 2022|Headlines|Comments Off on Vaccine T-cells may hold robust defensive line against Omicron variant: study